Indian pharmaceutical company Cipla has named Subhanu Saxena as its new chief executive officer, effective 1 February 2013.

Saxena worked with various companies including Citicorp, The Boston Consulting Group, PepsiCo and most recently Novartis Pharma leading its global product strategy and commercialization operations.

The new CEO will report to the Cipla chairman and the board of directors.

Commenting on the appointment, Cipla chairman Dr. Yusuf Hamied said, "I am confident Subhanu will build on Cipla's core values to deliver the next phase of growth, competitiveness and return on shareholder value."

Cipla, which has more than 34 manufacturing facilities across India, produces more than 2,000 products covering 65 therapeutic areas.